Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAgilon Health, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 6 | -$0.01 | $0.00 | -$0.00 |
| Q2 2025 | 10 | -$0.16 | -$0.05 | -$0.11 |
| Q3 2025 | 7 | -$0.19 | -$0.11 | -$0.15 |
| Q4 2025 | 4 | -$0.43 | -$0.11 | -$0.25 |
| Q1 2026 | 5 | -$0.24 | $0.11 | -$0.03 |
| Q2 2026 | 1 | -$0.13 | -$0.12 | -$0.13 |
| Q3 2026 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q4 2026 | 1 | -$0.16 | -$0.14 | -$0.15 |
| Q1 2027 | 1 | $0.10 | $0.10 | $0.10 |
| Q2 2027 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q3 2027 | 1 | -$0.12 | -$0.11 | -$0.11 |
| Q4 2027 | 1 | -$0.24 | -$0.22 | -$0.23 |
Agilon Health, Inc. Earnings Date And Information
Agilon Health, Inc. last posted its earnings results on Tuesday, November 4th, 2025. The company reported $-0.27 earnings per share for the quarter, missing analysts' consensus estimates of $-0.18 by $0.09. The company had revenue of 1.44 B for the quarter and had revenue of 6.06 B for the year. Agilon Health, Inc. has generated $-1 earnings per share over the last year ($-0.63 diluted earnings per share) and currently has a price-to-earnings ratio of -0.9. Agilon Health, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 24th, 2026 based on prior year's report dates.
Agilon Health, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/04/2025 | Q3 2025 | -$0.18 | -$0.27 | -0.09 | $1.42 B | $1.44 B |
| 08/04/2025 | Q2 2025 | -$0.11 | -$0.25 | -0.14 | $1.47 B | $1.39 B |
| 05/06/2025 | Q1 2025 | -$0.01 | $0.03 | 0.04 | N/A | $1.53 B |
| 02/25/2025 | Q4 2024 | -$0.18 | -$0.26 | -0.08 | N/A | $1.52 B |
| 11/07/2024 | Q3 2024 | -$0.10 | -$0.29 | -0.19 | $1.47 B | $1.45 B |
| 08/06/2024 | Q2 2024 | -$0.07 | -$0.07 | 0 | $1.54 B | $1.48 B |
| 05/07/2024 | Q1 2024 | $0.01 | -$0.01 | -0.02 | N/A | $1.60 B |
| 02/27/2024 | Q4 2023 | -$0.28 | -$0.56 | -0.28 | N/A | $815.50 M |
| 11/02/2023 | Q3 2023 | -$0.05 | -$0.08 | -0.03 | $1.13 B | $1.14 B |
| 08/03/2023 | Q2 2023 | -$0.03 | -$0.04 | -0.01 | $1.11 B | $1.07 B |
| 05/09/2023 | Q1 2023 | $0.02 | $0.04 | 0.02 | $1.08 B | $1.05 B |
| 03/01/2023 | Q4 2022 | -$0.08 | -$0.14 | -0.06 | $662.01 M | $689.77 M |
| 11/03/2022 | Q3 2022 | -$0.05 | -$0.07 | -0.02 | $662.21 M | $694.86 M |
| 08/04/2022 | Q2 2022 | -$0.01 | -$0.05 | -0.04 | $647.79 M | $670.13 M |
| 05/05/2022 | Q1 2022 | N/A | $0.00 | N/A | $642.87 M | $653.45 M |
| 03/03/2022 | Q4 2021 | -$0.12 | -$0.14 | -0.02 | $452.95 M | $462.89 M |
| 10/28/2021 | Q3 2021 | -$0.07 | -$0.09 | -0.02 | $450.52 M | $458.61 M |
| 08/04/2021 | Q2 2021 | -$0.05 | -$0.79 | -0.74 | $473.20 M | $498.96 M |
| 05/26/2021 | Q1 2021 | -$0.02 | -$0.05 | -0.02 | $405.86 M | $413.10 M |
| 12/30/2020 | Q4 2020 | N/A | -$0.07 | N/A | N/A | $321.01 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Agilon Health, Inc. Earnings: FAQ's
Agilon Health, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 24th, 2026 based offlast year's report dates.
The conference call for Agilon Health, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Agilon Health, Inc.'s latest earnings report can be read online.
Agilon Health, Inc. (:AGL) has a recorded annual revenue of $6.06 B.
Agilon Health, Inc. (:AGL) has a recorded net income of $-260,151,000.Agilon Health, Inc. has generated $-0.63 earnings per share over the last four quarters.
Agilon Health, Inc. (:AGL) has a price-to-earnings ratio of -0.9 and price/earnings-to-growth ratio is -0.35.